Cardiac sarcoidosis and ACM genetic variants coexist with distinct features, highlighting the need for refined clinical ...

Many interesting insights into the pathogenesis of tachycardia-induced cardiomyopathy have been ... microscopic and electrical dysfunction in the atrial and ventricular myocardium ( Table II).

The third pathway involves people whose hypertrophic cardiomyopathy leads to atrial fibrillation—a condition where the ...

Tachycardia-induced cardiomyopathy is a reversible cause of heart failure with myriad complex underlying mechanisms. In certain ways, this entity is similar to other causes of heart failure.

Verapamil has been studied to treat hypertrophic obstructive cardiomyopathy, as well as multifocal atrial tachycardia. Sublingual dihydropyridine calcium channel blockers such as nifedipine ...

Novartis AG has synthesized new sodium channel protein type 5 subunit alpha (SCN5A; Nav1.5) blockers reported to be useful for the treatment of heart failure, long QT syndrome, hypertrophic ...